by Truveta staff | May 19, 2023 | Technology
The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
by Truveta staff | May 5, 2023 | Technology
Medical device companies face a unique challenge when they want to study their product performance post-launch – a significant lack of detailed data on use of their device in clinical practice and the related outcomes. Understanding clinical outcomes or adverse events...
by Truveta staff | Apr 20, 2023 | Technology
Truveta is a healthcare company that is passionate about improving patient care and saving lives by harnessing the transformative potential of EHR data and artificial intelligence (AI). In a recent article from Microsoft that highlighted our vision and mission, “How...
by Terry Myerson, CEO | Apr 12, 2023 | News, Technology
UPDATE: Truveta has won the 2024 South by Southwest (SXSW) Innovation Award in Artificial Intelligence for its AI-enabled health research and the Truveta Language Model (TLM). Healthcare data traditionally has been siloed, inaccessible, and too messy to be useful for...
by Truveta staff | Feb 14, 2023 | Technology
It’s no secret — yet surprising and tragic — that the United States is one of the most dangerous high-income countries in which to give birth. It’s also unfortunately well known that nearly every maternal health outcome in the United States negatively affects women of...
by Truveta staff | Jan 10, 2023 | Technology
The key to any disease study is rich data. We recently met with the CEO of a biotech company that specializes in the development of immunotherapies. He and his team had tried to recruit patients for a series of clinical trials related to several rare disease...
